Azitra, Inc.

US$0.73As of Sun 8 Nov 2026, 12:00 UTC
AMEX:AZTRHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (93.54%)
Div yield —
ROE (256.67%)
Biotechnology
Beta (5Y) (0.90)
PE TTM —
TSR TTM (85.99%)
Mkt cap US$4.439M
ROIC (146.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.787
7.44%
79.69%
Hold 8|12|5|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
9.60%
6.93%
17.00%
12.28%
Revenue$M
0.272
0.284
0.293
0.295
3.47%
4.89%
4.63%
7.22%
Peers (US$4.439M)
Cap (US$)
PE
4.354M
—
Capital
TTM
5Y
10Y
Leveragex
0.920
(0.745)
(0.625)
EBIT/Intx
4.694
0.832
0.728
Own earn%
316.52
(16.55)
(29.48)
Sh yield%
26.11
26.46
25.75
Owners
Insiders/Inst%
11.89
36.90
Short interest%
2.77
SBC / revenue%
5.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
31–35
$1 testx
—
Incr. ROIC%
3